The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study-Reference-Cited by-同舟云学术

The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study

Published:2016-11-07 Issue:3 Volume:140 Page:618-625
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Shinagawa Takafumi¹,Kitamura Tetsuhisa¹,Katanoda Kota²,Matsuda Tomohiro²,Ito Yuri³,Sobue Tomotaka¹

Affiliation:

1. Department of Social Medicine, Division of Environmental Medicine and Population Sciences, Graduate School of Medicine; Osaka University; Osaka Japan

2. Center for Cancer Registries, Center for Cancer Control and Information Services, National Cancer Center; Tokyo Japan

3. Department of Cancer Epidemiology and Prevention; Center for Cancer Control and Statistics; Osaka Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.30482/fullpdf

Reference42 articles.

1. American Cancer Society http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf

2. Incidence and survival trends for childhood cancer in Osaka, Japan, 1973-2001;Baba;Cancer Sci,2010

3. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group;Sawada;Lancet,1984

4. Mass screening for neuroblastoma and mortality in birth cohorts;Nishi;Int J Cancer,1997

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of Pedriatic Cancer;International Encyclopedia of Public Health;2025

2. Prevalence of survivors of childhood cancer based on a population‐based cancer registry in Osaka, Japan;International Journal of Cancer;2024-04-12

3. BAP31 Promotes Angiogenesis via Galectin-3 Upregulation in Neuroblastoma;International Journal of Molecular Sciences;2024-03-03

4. A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019;Pediatric Blood & Cancer;2023-10-22

5. The burden of childhood and adolescent cancers in North Africa and the Middle East (NAME) region: findings from the Global Burden of Disease study 2019;BMC Pediatrics;2023-03-08